β 2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension(382 views) Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B
Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Dipartimento di Neuroscienze e Scienze del Comportamento, Università Federico II di Napoli, Italy
References: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension (2003) J Hypertens, 21, pp. 1011-105
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo Jr., J.L., The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report (2003) JAMA, 289, pp. 2560-2572
Frohlich, E.D., Apstein, C., Chobanian, A.V., Devereux, R.B., Dustan, H.P., Dzau, V., The heart in hypertension (1992) N Engl J Med, 327, pp. 998-1008
Adams, T.D., Yanowitz, F.G., Fisher, A.G., Ridges, J.D., Nelson, A.G., Hagan, A.D., Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins (1985) Circulation, 71, pp. 39-44
Harshfield, G.A., Grim, C.E., Hwang, C., Savage, D.D., Anderson, S.J., Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins (1990) Am J Hypertens, 3, pp. 538-543
Post, W.S., Larson, M.G., Myers, R.H., Galderisi, M., Levy, D., Heritability of left ventricular mass: the Framingham Heart Study (1997) Hypertension, 30, pp. 1025-1028
Turner, S.T., Boerwinkle, E., Genetics of hypertension, target-organ complications, and response to therapy (2000) Circulation, 102 (SUPPL. 4), pp. IV40-IV45
Iaccarino, G., Barbato, E., Cipoletta, E., Fiorillo, A., Trimarco, B., Role of the sympathetic nervous system in cardiac remodeling in hypertension (2001) Clin Exp Hypertens, 23, pp. 35-43
Akhter, S.A., Milano, C.A., Shotwell, K.F., Cho, M.C., Rockman, H.A., Lefkowitz, R.J., Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling (1997) J Biol Chem, 272, pp. 21253-21259
Engelhardt, S., Hein, L., Wiesmann, F., Lohse, M.J., Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice (1999) Proc Natl Acad Sci U S A, 96, pp. 7059-7064
Liggett, S.B., Tepe, N.M., Lorenz, J.N., Canning, A.M., Jantz, T.D., Mitarai, S., Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level (2000) Circulation, 101, pp. 1707-1714
Iaccarino, G., Tomhave, E.D., Lefkowitz, R.J., Koch, W.J., Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade (1998) Circulation, 98, pp. 1783-1789
Bono, M., Cases, A., Calls, J., Gaya, J., Jimenez, W., Carretero, J., Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension (1995) Am J Hypertens, 8 (PART 1), pp. 487-493
Laflamme, K.A., Oster, L., Cardinal, R., de Champlain, J., Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat (1997) Hypertension, 30 (PART 1), pp. 278-287
Liggett, S.B., Molecular and genetic basis of beta2-adrenergic receptor function (1999) J Allergy Clin Immunol, 104 (PART 2), pp. S42-S46
Bengtsson, K., Orho-Melander, M., Melander, O., Lindblad, U., Ranstam, J., Rastam, L., Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes (2001) Hypertension, 37, pp. 1303-1308
Bray, M.S., Boerwinkle, E., The role of beta(2)-adrenergic receptor variation in human hypertension (2000) Curr Hypertens Rep, 2, pp. 39-43
Gratze, G., Fortin, J., Labugger, R., Binder, A., Kotanko, P., Timmermann, B., beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians (1999) Hypertension, 33, pp. 1425-1430
Kotanko, P., Binder, A., Tasker, J., DeFreitas, P., Kamdar, S., Clark, A.J., Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor (1997) Hypertension, 30, pp. 773-776
Tomaszewski, M., Brain, N.J., Charchar, F.J., Wang, W.Y., Lacka, B., Padmanabahn, S., Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis (2002) Hypertension, 40, pp. 286-291
Iaccarino, G., Lanni, F., Cipolletta, E., Trimarco, V., Izzo, R., Iovino, G.L., The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension (2004) J Hypertens, 22, pp. 2117-2122
Bruck, H., Leineweber, K., Beilfuss, A., Weber, M., Heusch, G., Philipp, T., Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation (2003) Clin Pharmacol Ther, 74, pp. 255-263
Green, S.A., Turki, J., Bejarano, P., Hall, I.P., Liggett, S.B., Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells (1995) Am J Respir Cell Mol Biol, 13, pp. 25-33
Dishy, V., Sofowora, G.G., Xie, H.G., Kim, R.B., Byrne, D.W., Stein, C.M., The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization (2001) N Engl J Med, 345, pp. 1030-1035
Hoffmann, C., Leitz, M.R., Oberdorf-Maass, S., Lohse, M.J., Klotz, K.N., Comparative pharmacology of human beta-adrenergic receptor subtypes-characterization of stably transfected receptors in CHO cells (2004) Naunyn Schmiedebergs Arch Pharmacol, 369, pp. 151-159
Bohm, M., Grabel, C., Knorr, A., Erdmann, E., Treatment in hypertensive cardiac hypertrophy, I. Neuropeptide Y and beta-adrenoceptors (1995) Hypertension, 25, pp. 954-961
Zechner, D., Thuerauf, D.J., Hanford, D.S., McDonough, P.M., Glembotski, C.C., A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression (1997) J Cell Biol, 139, pp. 115-127
Sugden, P.H., Signalling pathways in cardiac myocyte hypertrophy (2001) Ann Med, 33, pp. 611-622
McDonald, P.H., Lefkowitz, R.J., Beta-Arrestins: new roles in regulating heptahelical receptors' functions (2001) Cell Signal, 13, pp. 683-689
De Luca, N., Izzo, R., Iaccarino, G., Malini, P.L., Morisco, C., Rozza, F., The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis (2005) J Hypertens, 23, pp. 1417-1423
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee (1999) J Hypertens, 17, pp. 151-183
Devereux, R.B., Alonso, D.R., Lutas, E.M., Gottlieb, G.J., Campo, E., Sachs, I., Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings (1986) Am J Cardiol, 57, pp. 450-458
Devereux, R.B., Reichek, N., Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method (1977) Circulation, 55, pp. 613-618
Large, V., Hellstrom, L., Reynisdottir, S., Lonnqvist, F., Eriksson, P., Lannfelt, L., Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function (1997) J Clin Invest, 100, pp. 3005-3013
Sahn, D.J., DeMaria, A., Kisslo, J., Weyman, A., Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements (1978) Circulation, 58, pp. 1072-1083
Ganau, A., Devereux, R.B., Roman, M.J., de Simone, G., Pickering, T.G., Saba, P.S., Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension (1992) J Am Coll Cardiol, 19, pp. 1550-1558
Iaccarino, G., Ciccarelli, M., Sorriento, D., Galasso, G., Campanile, A., Santulli, G., Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system (2005) Circ Res, 97, pp. 1182-1189
Rockman, H.A., Ross, R.S., Harris, A.N., Knowlton, K.U., Steinhelper, M.E., Field, L.J., Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy (1991) Proc Natl Acad Sci U S A, 88, pp. 8277-8281
Morisco, C., Seta, K., Hardt, S.E., Lee, Y., Vatner, S.F., Sadoshima, J., Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes (2001) J Biol Chem, 276, pp. 28586-28597
Xiang, F., Sakata, Y., Cui, L., Youngblood, J.M., Nakagami, H., Liao, J.K., Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4 (2006) Am J Physiol Heart Circ Physiol, 290, pp. H1997-H2006
Kupari, M., Hautanen, A., Lankinen, L., Koskinen, P., Virolainen, J., Nikkila, H., Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function (1998) Circulation, 97, pp. 569-575
Tamaki, S., Iwai, N., Tsujita, Y., Kinoshita, M., Genetic polymorphism of CYP11B2 gene and hypertension in Japanese (1999) Hypertension, 33 (PART 2), pp. 266-270
Schunkert, H., Hengstenberg, C., Holmer, S.R., Broeckel, U., Luchner, A., Muscholl, M.W., Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure (1999) Circulation, 99, pp. 2255-2260
Sasaki, M., Oki, T., Iuchi, A., Tabata, T., Yamada, H., Manabe, K., Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies (1996) J Hypertens, 14, pp. 1403-1408
Hernandez, D., Lacalzada, J., Salido, E., Linares, J., Barragan, A., Lorenzo, V., Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism (2000) Kidney Int, 58, pp. 889-897
Kohno, M., Yokokawa, K., Minami, M., Kano, H., Yasunari, K., Hanehira, T., Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors (1999) Am J Med, 106, pp. 544-549
Stella, P., Bigatti, G., Tizzoni, L., Barlassina, C., Lanzani, C., Bianchi, G., Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension (2004) J Am Coll Cardiol, 43, pp. 265-270
Littlejohn, M.D., Taylor, D.R., Miller, A.L., Kennedy, M.A., Determination of beta2-adrenergic receptor (ADRB2) haplotypes by a multiplexed polymerase chain reaction assay (2002) Hum Mutat, 20, p. 479
Taylor, D.R., Epton, M.J., Kennedy, M.A., Smith, A.D., Iles, S., Miller, A.L., Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma (2005) Am J Respir Crit Care Med, 172, pp. 700-703
Leineweber, K., Buscher, R., Bruck, H., Brodde, O.E., Beta-adrenoceptor polymorphisms (2004) Naunyn Schmiedebergs Arch Pharmacol, 369, pp. 1-22
Arnett, D.K., de las Fuentes, L., Broeckel, U., Genes for left ventricular hypertrophy (2004) Curr Hypertens Rep, 6, pp. 36-41
Fagard, R., Staessen, J., Thijs, L., Amery, A., Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A metaanalysis of comparative studies (1995) Am J Hypertens, 8 (PART 1), pp. 533-540
Wadworth, A.N., Murdoch, D., Brogden, R.N., Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders (1991) Drugs, 42, pp. 468-510
Sakata, K., Shirotani, M., Yoshida, H., Kurata, C., Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension (1998) J Am Coll Cardiol, 32, pp. 438-443
Dahlof, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G., de Faire, U., Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002) Lancet, 359, pp. 995-1003
Trimarco, B., Ricciardelli, B., De Luca, N., De Simone, A., Cuocolo, A., Galva, M.D., Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents (1985) Circulation, 72, pp. 38-46
β 2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension